1. Home
  2. SCZM vs CERS Comparison

SCZM vs CERS Comparison

Compare SCZM & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Santacruz Silver Mining Ltd. Common Shares

SCZM

Santacruz Silver Mining Ltd. Common Shares

N/A

Current Price

$8.42

Market Cap

585.2M

Sector

N/A

ML Signal

N/A

Logo Cerus Corporation

CERS

Cerus Corporation

HOLD

Current Price

$2.41

Market Cap

585.1M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCZM
CERS
Founded
N/A
1991
Country
Canada
United States
Employees
455
N/A
Industry
EDP Services
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
585.2M
585.1M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
SCZM
CERS
Price
$8.42
$2.41
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$12.00
N/A
AVG Volume (30 Days)
395.4K
2.6M
Earning Date
05-29-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
27.27
EPS
N/A
N/A
Revenue
N/A
$51,326,000.00
Revenue This Year
$79.38
$19.95
Revenue Next Year
N/A
$8.84
P/E Ratio
$14.27
N/A
Revenue Growth
N/A
30.68
52 Week Low
$5.61
$1.15
52 Week High
$17.65
$3.47

Technical Indicators

Market Signals
Indicator
SCZM
CERS
Relative Strength Index (RSI) 67.30 34.29
Support Level $5.95 $1.84
Resistance Level $8.40 $2.84
Average True Range (ATR) 0.42 0.17
MACD 0.22 -0.10
Stochastic Oscillator 93.42 22.22

Price Performance

Historical Comparison
SCZM
CERS

About SCZM Santacruz Silver Mining Ltd. Common Shares

Santacruz Silver Mining Ltd is engaged in the operation, acquisition, exploration, and development of mineral properties in Latin America, with a primary focus on silver and zinc, including lead and copper. The company earns the majority of its revenue from Zinc and Silver. The company's reportable operating segments are the Bolivar mine and processing plant, the Porco mine and processing plant, the Caballo Blanco Group, San Lucas, Zimapa mine and processing plant, and Corporate and Other activities. Key revenue is generated from Zimapan.

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety, and generates revenue from the same.

Share on Social Networks: